Pierre Savi Roberto Lorenzet

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Clopidogrel is considered to be an important therapeutic advance in anti-platelet therapy. We investigated whether inhibition by clopidogrel results in a reduced capacity of platelets to adhere and stimulate pro-atherothrombotic and inflammatory functions in polymorphonuclear leukocytes (PMN) and in monocytes (MN). An eventual effect on these processes(More)
  • 1